UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Osimertinib Should Not Yet Be Considered the Standard of Care for EGFR-Mutant NSCLC in the Adjuvant Setting

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.371-374

Uprety, Dipesh

2021

Volltextzugriff (PDF)

Chemoimmunotherapy for stage IV non-small-cell lung cancer

The lancet oncology, 2019-09, Vol.20 (9), p.e466-e466

Uprety, Dipesh

2019

Volltextzugriff (PDF)

CheckMate 743: A Glimmer of Hope for Malignant Pleural Mesothelioma

Clinical lung cancer, 2021-03, Vol.22 (2), p.71-73

Uprety, Dipesh

2021

Volltextzugriff (PDF)

KRAS: From undruggable to a druggable Cancer Target

Cancer treatment reviews, 2020-09, Vol.89, p.102070-102070, Article 102070

2020

Volltextzugriff (PDF)

Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer

Clinical lung cancer, 2019-03, Vol.20 (2), p.63-65

Uprety, Dipesh

2019

Volltextzugriff (PDF)

Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future Approaches

Journal of thoracic oncology, 2020-08, Vol.15 (8), p.1281-1297

2020

Volltextzugriff (PDF)

First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?

Journal of clinical oncology, 2024-02, Vol.42 (4), p.378

2024

Volltextzugriff (PDF)

ChatGPT—A promising generative AI tool and its implications for cancer care

Cancer, 2023-08, Vol.129 (15), p.2284-2289

2023

Volltextzugriff (PDF)

All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1429-1433

2021

Volltextzugriff (PDF)

Survival trends among patients with metastatic non–small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database–based study

Cancer, 2024-07

2024

Volltextzugriff (PDF)

MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1

Stem cells (Dayton, Ohio), 2016-05, Vol.34 (5), p.1284-1296

2016

Volltextzugriff (PDF)

Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature

Annals of hematology, 2014-05, Vol.93 (5), p.769-771

2014

Volltextzugriff (PDF)

Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments

Current treatment options in oncology, 2020-08, Vol.21 (11), p.86-86, Article 86

2020

Volltextzugriff (PDF)

Malignant Pericardial Effusion, or Fluid Around the Heart Due to Cancer

JAMA oncology, 2024-01, Vol.10 (1), p.148

2024

Volltextzugriff (PDF)

MET alterations in NSCLC—Current Perspectives and Future Challenges

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.419-435

2023

Volltextzugriff (PDF)

Racial and socioeconomic disparities in survival among patients with metastatic non–small cell lung cancer

JNCI : Journal of the National Cancer Institute, 2024-06

2024

Volltextzugriff (PDF)

Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer

Cancer research and treatment, 2022-04, Vol.54 (2), p.315-329

2022

Volltextzugriff (PDF)

Perioperative Therapy for Resectable Non-Small-Cell Lung Cancer: Weighing Options for the Present and Future

JCO oncology practice, 2023-07, Vol.19 (7), p.403-409

2023

Volltextzugriff (PDF)

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30 + Malignancies

Clinical cancer research, 2021-07, Vol.27 (13), p.3744-3756

2021

Volltextzugriff (PDF)

A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors

Cancers, 2023-04, Vol.15 (9), p.2553

2023

Volltextzugriff (PDF)

A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms

Current problems in cancer. Case reports, 2024-03, Vol.13, p.100284, Article 100284

2024

Volltextzugriff (PDF)

Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study

Melanoma research, 2018-02, Vol.28 (1), p.56-60

2018

Volltextzugriff (PDF)

The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients

Clinical Medicine Insights. Oncology, 2018, Vol.12, p.1179554918779585-1179554918779585

2018

Volltextzugriff (PDF)

Renal failure secondary to leukemic infiltration of kidneys in CLL—a case report and review of literature

Annals of hematology, 2013-01, Vol.92 (2), p.271-273

2013

Volltextzugriff (PDF)

The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study

Acta oncologica, 2018-02, Vol.57 (2), p.239-243

2018

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(46)
Buchkapitel
(1)

Sprache

Englisch
(47)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(46)
Science & Technology
(46)
Humans
(27)
Lung Neoplasms - Drug Therapy
(11)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(8)
Male
(8)
Female
(7)
Middle Aged
(7)
Nsclc
(7)
Respiratory System
(7)
Aged
(6)
Immunotherapy
(6)
Lung Neoplasms - Genetics
(6)
Lung Neoplasms - Pathology
(6)
Mutation
(6)
Cancer
(5)
Carcinoma, Non-Small-Cell Lung - Genetics
(5)
Chemotherapy
(5)
Hematology
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Osimertinib Should Not Yet Be Considered the Standard of Care for EGFR-Mutant NSCLC in the Adjuvant Setting

Chemoimmunotherapy for stage IV non-small-cell lung cancer

CheckMate 743: A Glimmer of Hope for Malignant Pleural Mesothelioma

KRAS: From undruggable to a druggable Cancer Target

Chemo-immunotherapy: The Beginning of a New Era in Lung Cancer

Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future Approaches

First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?

ChatGPT—A promising generative AI tool and its implications for cancer care

All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

Survival trends among patients with metastatic non–small cell lung cancer before and after the approval of immunotherapy in the United States: A Surveillance, Epidemiology, and End Results database–based study

MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1

Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature

Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments

Malignant Pericardial Effusion, or Fluid Around the Heart Due to Cancer

MET alterations in NSCLC—Current Perspectives and Future Challenges

Racial and socioeconomic disparities in survival among patients with metastatic non–small cell lung cancer

Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer

Perioperative Therapy for Resectable Non-Small-Cell Lung Cancer: Weighing Options for the Present and Future

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30 + Malignancies

A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors

A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms

Survival trends among patients with metastatic melanoma in the pretargeted and the post-targeted era: a US population-based study

The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients

Renal failure secondary to leukemic infiltration of kidneys in CLL—a case report and review of literature

The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study

Aktive Filter

Suchergebnisse filtern